Silvia Cerri

3.1k total citations · 1 hit paper
61 papers, 2.3k citations indexed

About

Silvia Cerri is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Silvia Cerri has authored 61 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 22 papers in Cellular and Molecular Neuroscience and 15 papers in Physiology. Recurrent topics in Silvia Cerri's work include Parkinson's Disease Mechanisms and Treatments (36 papers), Lysosomal Storage Disorders Research (11 papers) and Nerve injury and regeneration (9 papers). Silvia Cerri is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (36 papers), Lysosomal Storage Disorders Research (11 papers) and Nerve injury and regeneration (9 papers). Silvia Cerri collaborates with scholars based in Italy, United States and United Kingdom. Silvia Cerri's co-authors include Fabio Blandini, Giulia Ambrosi, Marie‐Thérèse Armentero, Cristina Ghezzi, Micol Avenali, Giovanna Levandis, Pier G. Mastroberardino, Chiara Milanese, Francesca Siani and Claudio Giuliano and has published in prestigious journals such as Brain, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Silvia Cerri

58 papers receiving 2.3k citations

Hit Papers

Parkinson’s Disease in Women and Men: What’s the Difference? 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Cerri Italy 26 1.1k 714 584 473 336 61 2.3k
Anmu Xie China 25 743 0.7× 723 1.0× 397 0.7× 407 0.9× 350 1.0× 99 2.1k
Shu‐Leong Ho Hong Kong 31 1.1k 1.0× 873 1.2× 518 0.9× 619 1.3× 271 0.8× 52 2.6k
Jinsha Huang China 22 810 0.8× 631 0.9× 428 0.7× 343 0.7× 370 1.1× 47 2.0k
Masayo Fujita Japan 28 940 0.9× 1.0k 1.4× 572 1.0× 571 1.2× 593 1.8× 64 2.7k
Wenjie Xie China 23 822 0.8× 687 1.0× 723 1.2× 329 0.7× 399 1.2× 55 2.1k
Patrizia Longone Italy 31 983 0.9× 881 1.2× 913 1.6× 347 0.7× 336 1.0× 63 2.6k
С. Н. Иллариошкин Russia 25 816 0.8× 1.1k 1.6× 859 1.5× 445 0.9× 231 0.7× 308 2.3k
Naomi P. Visanji Canada 26 1.8k 1.7× 806 1.1× 1.0k 1.7× 527 1.1× 388 1.2× 62 3.0k
Iddo Magen Israel 24 840 0.8× 598 0.8× 617 1.1× 402 0.8× 215 0.6× 38 2.0k
Matthew Fell United Kingdom 18 798 0.8× 682 1.0× 510 0.9× 456 1.0× 155 0.5× 56 1.9k

Countries citing papers authored by Silvia Cerri

Since Specialization
Citations

This map shows the geographic impact of Silvia Cerri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Cerri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Cerri more than expected).

Fields of papers citing papers by Silvia Cerri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Cerri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Cerri. The network helps show where Silvia Cerri may publish in the future.

Co-authorship network of co-authors of Silvia Cerri

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Cerri. A scholar is included among the top collaborators of Silvia Cerri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Cerri. Silvia Cerri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Derkinderen, Pascal, François Cossais, Matěj Škorvánek, et al.. (2025). How leaky is the gut in Parkinson’s disease?. EBioMedicine. 117. 105796–105796. 1 indexed citations
2.
Grillo, Piergiorgio, Roberto De Icco, Roberto Bottinelli, et al.. (2025). Physical exercise modulates plasma irisin levels in endurance athletes: Implications for Parkinson's disease. Neurobiology of Disease. 215. 107065–107065.
3.
Avenali, Micol, Silvia Cerri, Ilaria Palmieri, et al.. (2024). Functional Study of SNCA p.V15A Variant: Further Linking α‐Synuclein and Glucocerebrosidase. Movement Disorders. 39(6). 1060–1065.
4.
Ghezzi, Cristina, Antonio Pisani, Michele Terzaghi, et al.. (2023). Impaired Mitochondrial Respiration in REM‐Sleep Behavior Disorder: A Biomarker of Parkinson's Disease?. Movement Disorders. 39(2). 294–304. 7 indexed citations
5.
Pisani, Silvia, Silvia Cerri, Ida Genta, et al.. (2023). Investigation and Comparison of Active and Passive Encapsulation Methods for Loading Proteins into Liposomes. International Journal of Molecular Sciences. 24(17). 13542–13542. 26 indexed citations
6.
Ponterio, Giulia, Gaia Faustini, Giuseppe Sciamanna, et al.. (2022). Alpha‐Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction. Movement Disorders. 37(5). 949–961. 7 indexed citations
7.
Galvagnion, Céline, et al.. (2021). Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation. Brain. 145(3). 1038–1051. 57 indexed citations
8.
Imbriani, Paola, et al.. (2021). Synaptic effects of ethanol on striatal circuitry: therapeutic implications for dystonia. FEBS Journal. 289(19). 5834–5849. 6 indexed citations
9.
Cerri, Silvia, et al.. (2021). Are Lysosomes Potential Therapeutic Targets for Parkinson’s Disease?. CNS & Neurological Disorders - Drug Targets. 21(8). 642–655. 3 indexed citations
10.
Pellegrini, Carolina, Chiara Ippolito, Cristina Segnani, et al.. (2020). Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration. Neurobiology of Disease. 139. 104821–104821. 30 indexed citations
11.
Avenali, Micol, Fabio Blandini, & Silvia Cerri. (2020). Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease. Frontiers in Aging Neuroscience. 12. 97–97. 64 indexed citations
12.
Manni, Raffaele, Riccardo Cremascoli, Roberto De Icco, et al.. (2019). Evening melatonin timing secretion in real life conditions in patients with Alzheimer disease of mild to moderate severity. Sleep Medicine. 63. 122–126. 28 indexed citations
13.
Cerri, Silvia, et al.. (2019). Parkinson’s Disease in Women and Men: What’s the Difference?. Journal of Parkinson s Disease. 9(3). 501–515. 494 indexed citations breakdown →
14.
Cerri, Silvia & Fabio Blandini. (2018). Role of Autophagy in Parkinson’s Disease. Current Medicinal Chemistry. 26(20). 3702–3718. 88 indexed citations
16.
Siani, Francesca, et al.. (2018). Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity. Neurobiology of Disease. 124. 289–296. 23 indexed citations
17.
Sepe, Sara, Chiara Milanese, Kasper Derks, et al.. (2016). Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson’s Disease. Cell Reports. 15(9). 1866–1875. 101 indexed citations
18.
Cerri, Silvia, Giada Santin, Maria Grazia Bottone, et al.. (2010). The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum. Neurotoxicology and Teratology. 33(2). 273–281. 33 indexed citations
19.
Cerri, Silvia, et al.. (2010). Postnatal Development of the Central Nervous System: Anomalies in the Formation of Cerebellum Fissures. The Anatomical Record. 293(3). 492–501. 13 indexed citations
20.
Cerri, Silvia, Giovanni Bottiroli, Maria Grazia Bottone, Sergio Barni, & Graziella Bernocchi. (2009). Cell proliferation and death in the brain of active and hibernating frogs. Journal of Anatomy. 215(2). 124–131. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026